SCHEMBL965500

SCHEMBL965500

C=C(C)C(=O)OC1=NCCO1

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
KMT2A Q03164 1/20 0.33
ATM Q13315 1/20 0.33
ELANE P08246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8656142 0.81
SCHEMBL28301898 0.79 KDM4E (0.34)
SCHEMBL28275692 0.79 KDM4E (0.34)
SCHEMBL4864552 0.76
Formaldehyde SCHEMBL28078018 0.74 KDM4E (0.30)
SCHEMBL28170502 0.74 KDM4E (0.36) ALDH1A1
SCHEMBL4860730 0.73 HDAC3 (0.33)
SCHEMBL965609 0.73 THRB (0.31)
SCHEMBL393157 0.73 ESR1 (0.33) ALDH1A1KMT2AELANE
SCHEMBL27729063 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 121 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6300406-B1 USED IN ENDLESS SEAMLESS BELT HAVING THE ABOVE COMPOSITION IS SUITED AS AN INTERMEDIATE IMAGE TRANSFER ELEMENT FOR AN ELECTROPHOTOGRAPHIC IMAGE FORMING APPARATUS OKURA INDUSTRIAL CO., LTD. (JP) 2001-10-09 US claimed
US-6433116-B1 None US disclosed
US-20240271176-A1 POLYMERIC ORGANOMETALLIC REDOX MEDIATOR FOR CONTINUOUS KETONE AND GLUCOSE MONITORING Evolve Scientific Solutions LLC 2024-08-15 US disclosed
WO-2024167483-A1 POLYMERIC ORGANOMETALLIC REDOX MEDIATOR FOR CONTINUOUS KETONE AND GLUCOSE MONITORING Evolve Scientific Solutions LLC (US) 2024-08-15 WO disclosed
US-20240053292-A1 POLYMERIC ORGANOMETALLIC REDOX MEDIATOR FOR CONTINUOUS KETONE AND GLUCOSE MONITORING Evolve Scientific Solutions LLC 2024-02-15 US disclosed
US-11111320-B2 Addition-fragmentation oligomers 3M INNOVATIVE PROPERTIES COMPANY (US) 2021-09-07 US disclosed
CN-107406723-B Addition-fragmentation oligomers 3M创新有限公司 2021-05-07 CN disclosed
EP-2675783-B1 ADDITION-FRAGMENTATION AGENTS 3M INNOVATIVE PROPERTIES CO (US) 2020-04-22 EP disclosed
EP-3259323-B1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2020-02-26 EP disclosed
US-20200031961-A1 ADDITION-FRAGMENTATION OLIGOMERS 3M INNOVATIVE PROPERTIES CO (US) 2020-01-30 US disclosed
CN-1311274-A Method for prepn. of removable type coating composition ROHM & HAAS (US) 2001-09-05 CN disclosed
US-20010018516-A1 Oxazoline or oxazine acetoacetate aqueous coating compositions BASF CORPORATION 2001-08-30 US disclosed
US-6235901-B1 CAN BE POLYMERIZED AND/OR COPOLYMERIZED BY CATONIC POLYMERIZATION; CAN BE CROSSLINKED AND ARE USEFUL IN COATINGS, INKS, OVERPRINT VARNISHES, AND SURFACE TREATMENT APPLICATIONS. S. C. JOHNSON COMMERCIAL MARKETS, INC. 2001-05-22 US disclosed
WO-2001025348-A1 OXAZOLINE OR OXAZINE COATING COMPOSITIONS JOHNSON POLYMER, INC. (US) 2001-04-12 WO disclosed
WO-2000068212-A1 OXAZOLINE OR OXAZINE ACETOACETATE AQUEOUS COATING COMPOSITIONS S. C. JOHNSON COMMERCIAL MARKETS, INC. (US) 2000-11-16 WO disclosed
US-6084023-A ROOM TEMPERATURE SELF-CROSSLINKING LATEX CONTAINING WATER SOLUBLE SUPPORT RESIN HAVING PENDANT ACID GROUPS WHICH ARE REACTIVE WITH OXAZOLINE OR OXAZINE GROUPS AND ANOTHER MONOMER WHICH WILL NOT REACT WITH THEM, INKS, VARNISHES S. C. JOHNSON COMMERCIAL MARKETS, INC. (US) 2000-07-04 US disclosed
EP-0808348-B1 CROSS-LINKABLE PRESSURE SENSITIVE ADHESIVE AND PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE MINNESOTA MINING & MFG (US) 1999-05-06 EP disclosed
US-5741543-A CONTAINING UNSATURATED MONOMERS MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1998-04-21 US disclosed
EP-0808348-A1 PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1997-11-26 EP disclosed
WO-1996024644-A1 PROCESS FOR THE PRODUCTION OF AN ARTICLE COATED WITH A CROSSLINKED PRESSURE SENSITIVE ADHESIVE MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1996-08-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200031961-A1 ADDITION-FRAGMENTATION OLIGOMERS ECPAS, ITGA8, NBAS ALDH1A1 2212/4885KMT2A 2118/4885ATM 3388/4885
US-11111320-B2 Addition-fragmentation oligomers ECPAS, ITGA8, NBAS ALDH1A1 2212/4885KMT2A 2118/4885ATM 3388/4885
US-20010018516-A1 Oxazoline or oxazine acetoacetate aqueous coating compositions ITGB7, DNMT3A, KAT7 ALDH1A1 79/4885KMT2A 344/4885ATM 3356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.